Gang (Gary) Hao

Gang (Gary) Hao has a wealth of experience in the biopharmaceutical industry. Gang (Gary) began their career in 2007 as a Scientist - Senior Scientist at Progenics Pharmaceuticals, Inc. In 2010, they moved to EMD Serono, Inc., where they served as a Senior Scientist. In 2016, they joined Alkermes as a Principal Scientist. In 2018, they were appointed Director, Biologics CMC at TG Therapeutics, Inc. In 2021, they were promoted to Vice President, Analytical and Formulation Development at Codiak BioSciences. Most recently, in 2022, they were appointed Vice President, CMC at Vesigen Therapeutics, Inc.

Gang (Gary) Hao obtained a Bachelor of Science - BS in Biochemistry from Nankai University, followed by a Doctor of Philosophy (Ph.D.) in Pharmacology from Joan & Sanford I. Weill Medical College of Cornell University.